Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 3
2010 2
2011 3
2012 9
2013 12
2014 10
2015 27
2016 25
2017 23
2018 18
2019 17
2020 24
2021 42
2022 40
2023 46
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence for natural product drug discovery.
Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, Meijer D, Terlouw BR, Biermann F, Blin K, Durairaj J, Gorostiola González M, Helfrich EJN, Huber F, Leopold-Messer S, Rajan K, de Rond T, van Santen JA, Sorokina M, Balunas MJ, Beniddir MA, van Bergeijk DA, Carroll LM, Clark CM, Clevert DA, Dejong CA, Du C, Ferrinho S, Grisoni F, Hofstetter A, Jespers W, Kalinina OV, Kautsar SA, Kim H, Leao TF, Masschelein J, Rees ER, Reher R, Reker D, Schwaller P, Segler M, Skinnider MA, Walker AS, Willighagen EL, Zdrazil B, Ziemert N, Goss RJM, Guyomard P, Volkamer A, Gerwick WH, Kim HU, Müller R, van Wezel GP, van Westen GJP, Hirsch AKH, Linington RG, Robinson SL, Medema MH. Mullowney MW, et al. Among authors: du c. Nat Rev Drug Discov. 2023 Nov;22(11):895-916. doi: 10.1038/s41573-023-00774-7. Epub 2023 Sep 11. Nat Rev Drug Discov. 2023. PMID: 37697042 Review.
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.
Wen X, Xu P, Zeng X, Liu J, Du C, Zeng X, Cheng X, Wang X, Liang Y, Zhao T, Yang H, Li H, Meng L, Fang J, Liu H, Zhou Z, Zhang J, Zhang X, Guo Z, Chen X. Wen X, et al. Among authors: du c. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2846-2860. doi: 10.1007/s00259-023-06229-w. Epub 2023 Apr 25. Eur J Nucl Med Mol Imaging. 2023. PMID: 37097443
Levetiracetam for the treatment of status epilepticus.
Zheng F, Du C, Wang X. Zheng F, et al. Among authors: du c. Expert Rev Neurother. 2015 Oct;15(10):1113-21. doi: 10.1586/14737175.2015.1088785. Expert Rev Neurother. 2015. PMID: 26416394 Review.
Feeding mode influences dynamic gut microbiota signatures and affects susceptibility to anti-CD3 mAb-induced intestinal injury in neonatal mice.
Subramanian S, Geng H, Du C, Chou PM, Bu HF, Wang X, Swaminathan S, Tan SC, Ridlon JM, De Plaen IG, Tan XD. Subramanian S, et al. Among authors: du c. Am J Physiol Gastrointest Liver Physiol. 2022 Sep 1;323(3):G205-G218. doi: 10.1152/ajpgi.00337.2021. Epub 2022 Jul 12. Am J Physiol Gastrointest Liver Physiol. 2022. PMID: 35819158 Free PMC article.
Total synthesis of (±)-antroquinonol.
Wang X, Du C, Hong B, Lei X. Wang X, et al. Among authors: du c. Org Biomol Chem. 2019 Feb 13;17(7):1754-1757. doi: 10.1039/c8ob02494d. Org Biomol Chem. 2019. PMID: 30418462
Sparse coding with memristor networks.
Sheridan PM, Cai F, Du C, Ma W, Zhang Z, Lu WD. Sheridan PM, et al. Among authors: du c. Nat Nanotechnol. 2017 Aug;12(8):784-789. doi: 10.1038/nnano.2017.83. Epub 2017 May 22. Nat Nanotechnol. 2017. PMID: 28530717
284 results